US Stock MarketDetailed Quotes
EVGN Evogene
- 2.4000
- +0.2600+12.15%
Close Oct 18 16:00 ET
- 2.4000
- 0.00000.00%
Post 20:02 ET
12.88MMarket Cap-625P/E (TTM)
2.4000High2.2000Low73.56KVolume2.2000Open2.1400Pre Close166.37KTurnover1.48%Turnover RatioLossP/E (Static)5.37MShares10.400052wk High4.20P/B11.92MFloat Cap2.140052wk Low--Dividend TTM4.97MShs Float203.8900Historical High--Div YieldTTM9.35%Amplitude2.1400Historical Low2.2610Avg Price1Lot Size
Evogene Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 39.76%914K | 553.67%4.19M | 236.72%5.64M | -12.42%578K | 708.37%3.77M | 109.62%654K | 170.46%641K | 80.11%1.68M | 112.22%660K | 208.61%466K |
| Operating revenue | 39.76%914K | 553.67%4.19M | 236.72%5.64M | -12.42%578K | 708.37%3.77M | 109.62%654K | 170.46%641K | 80.11%1.68M | 112.22%660K | 208.61%466K |
| Cost of revenue | 16.49%537K | -3.73%310K | 86.14%1.69M | 9.34%398K | 325.83%511K | 75.95%461K | 97.55%322K | 18.51%909K | 36.33%364K | 18.81%120K |
| Gross profit | 95.34%377K | 1,116.30%3.88M | 415.40%3.95M | -39.19%180K | 841.04%3.26M | 286.00%193K | 331.08%319K | 369.94%766K | 572.73%296K | 592.00%346K |
| Operating expense | -19.95%6.48M | 11.96%7.97M | 9.92%30.46M | 91.47%7.81M | -0.05%7.44M | 0.46%8.09M | -12.47%7.12M | -10.96%27.71M | -53.32%4.08M | -13.51%7.44M |
| Selling and administrative expenses | -9.80%2.46M | 14.30%2.65M | -7.07%9.68M | -19.89%2.26M | -2.90%2.38M | 3.22%2.73M | -7.51%2.32M | 4.24%10.42M | -40.38%2.83M | 22.11%2.45M |
| -Selling and marketing expense | 0.00%928K | 24.00%992K | -0.49%1.01M | 10.40%-1.57M | -5.03%850K | -3.53%928K | -11.89%800K | 55.44%1.02M | ---1.75M | --895K |
| -General and administrative expense | -14.86%1.53M | 9.17%1.65M | -7.78%8.67M | -16.26%3.83M | -1.68%1.53M | 7.09%1.8M | -5.02%1.52M | 0.66%9.4M | 12.00%4.58M | -22.55%1.55M |
| Research and development costs | -25.20%4.02M | 0.02%4.8M | -0.07%20.78M | 16.66%5.55M | 1.34%5.06M | -0.89%5.37M | -14.68%4.8M | -1.58%20.79M | 18.88%4.75M | -24.33%5M |
| Other operating expenses | --5K | --519K | ---- | ---- | ---- | ---- | ---- | ---3.5M | ---- | ---- |
| Operating profit | 22.77%-6.1M | 39.88%-4.09M | 1.61%-26.51M | -101.69%-7.63M | 41.06%-4.18M | 1.32%-7.9M | 15.63%-6.8M | 12.96%-26.94M | 56.49%-3.78M | 17.05%-7.1M |
| Net non-operating interest income expense | -4.17%138K | 204.78%241K | 511.39%975K | -71.30%741K | 624.59%320K | 108.43%144K | 78.07%-230K | 12.22%-237K | 1,466.14%2.58M | -127.60%-61K |
| Non-operating interest income | -33.50%260K | 32.14%407K | 585.71%1.25M | 124.14%120K | 121.13%429K | -11.94%391K | 651.22%308K | -37.46%182K | 29.60%-497K | -48.95%194K |
| Non-operating interest expense | -50.61%122K | -69.14%166K | -30.30%115K | 76.63%-779K | -57.25%109K | -88.53%247K | -50.64%538K | -47.62%165K | -336.83%-3.33M | 60.38%255K |
| Total other finance cost | ---- | ---- | -37.80%158K | ---- | ---- | ---- | ---- | 3.25%254K | ---- | ---- |
| Other net income (expense) | 82.38%-454K | -425.66%-2.58M | ||||||||
| Gain on sale of security | ---- | ---- | 82.38%-454K | ---- | ---- | ---- | ---- | -425.66%-2.58M | ---- | ---- |
| Earnings from equity interest | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Income before tax | 22.86%-5.98M | 45.27%-3.85M | 12.66%-25.99M | -94.41%-7.34M | 46.03%-3.86M | 20.16%-7.76M | 22.83%-7.03M | 2.23%-29.75M | 53.33%-3.78M | 14.12%-7.16M |
| Income tax | -95.24%1K | 0 | -136.67%-33K | -108.89%-4K | -200.00%-5K | -44.74%21K | -2,350.00%-45K | 592.31%90K | 850.00%45K | -37.50%5K |
| Net income | 23.05%-5.99M | 44.92%-3.85M | 13.03%-25.95M | -92.02%-7.34M | 46.14%-3.86M | 20.26%-7.78M | 23.34%-6.98M | 1.97%-29.84M | 52.73%-3.82M | 14.14%-7.16M |
| Net income continuous Operations | 23.05%-5.99M | 44.92%-3.85M | 13.03%-25.95M | -92.02%-7.34M | 46.14%-3.86M | 20.26%-7.78M | 23.34%-6.98M | 1.97%-29.84M | 52.73%-3.82M | 14.14%-7.16M |
| Minority interest income | 25.03%-566K | 102.54%18K | 35.28%-2.08M | 10.57%-736K | 120.36%126K | 19.08%-755K | 14.56%-710K | -20.89%-3.21M | -15.43%-823K | 15.55%-619K |
| Net income attributable to the parent company | 22.84%-5.42M | 38.40%-3.86M | 10.36%-23.88M | -120.18%-6.6M | 39.12%-3.98M | 20.38%-7.02M | 24.22%-6.27M | 4.16%-26.64M | 59.33%-3M | 14.01%-6.54M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 22.84%-5.42M | 38.40%-3.86M | 10.36%-23.88M | -120.18%-6.6M | 39.12%-3.98M | 20.38%-7.02M | 24.22%-6.27M | 4.16%-26.64M | 59.33%-3M | 14.01%-6.54M |
| Basic earnings per share | 93.93%-1.02 | 46.67%-0.8 | 20.00%-5.2 | -85.71%-1.3 | 50.00%-0.8 | -700.00%-16.8 | 25.00%-1.5 | 5.80%-6.5 | 61.11%-0.7 | 15.79%-1.6 |
| Diluted earnings per share | 93.93%-1.02 | 46.67%-0.8 | 20.00%-5.2 | -85.71%-1.3 | 50.00%-0.8 | -700.00%-16.8 | 25.00%-1.5 | 5.80%-6.5 | 61.11%-0.7 | 15.79%-1.6 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data